FDA Grants Breakthrough Status to AMR Rapid Tests
Innovative Diagnostics Target Critical Drug Resistance February 18, 2026 | Santa Maria, California U.S. Food and Drug Administration has...
artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Eli Lilly FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology NSCLC Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
Innovative Diagnostics Target Critical Drug Resistance February 18, 2026 | Santa Maria, California U.S. Food and Drug Administration has...
HALIFAX, NOVA SCOTIA | December 30, 2025 — MedMira Inc. reported its first-quarter FY2026 results, highlighting a pivotal period...
